← Eichor
Study identifier: NCT06554327 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens

Condition: Ventilator Associated Pneumonia  ·  Sponsor: CHU de Reims

PhaseNA
Planned participants265
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveolar lavage (BAL) is used for microbiological diagnosis, with bacterial culture and antibiotic susceptibility results within 48 to 72 hours. Multiplex PCR can detect DNA of a number of bacteriae, as well as the presence of resistance genes. However, its clinical value in the ICU remains to be demonstrated. We think that the use of multiplex PCR with a panel adapted to the microbiology of VAP, could be an interesting method for clinicians in ICU.

This description comes directly from the study's public registry record.

Talk to the study team

Antoine GOURY  ·  03 10 73 68 85  ·  agoury@chu-reims.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Damien JOLLYReims, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06554327